These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 22101034

  • 1. Salivaricin D, a novel intrinsically trypsin-resistant lantibiotic from Streptococcus salivarius 5M6c isolated from a healthy infant.
    Birri DJ, Brede DA, Nes IF.
    Appl Environ Microbiol; 2012 Jan; 78(2):402-10. PubMed ID: 22101034
    [Abstract] [Full Text] [Related]

  • 2. Salivaricin 9, a new lantibiotic produced by Streptococcus salivarius.
    Wescombe PA, Upton M, Renault P, Wirawan RE, Power D, Burton JP, Chilcott CN, Tagg JR.
    Microbiology (Reading); 2011 May; 157(Pt 5):1290-1299. PubMed ID: 21310787
    [Abstract] [Full Text] [Related]

  • 3. Megaplasmids encode differing combinations of lantibiotics in Streptococcus salivarius.
    Wescombe PA, Burton JP, Cadieux PA, Klesse NA, Hyink O, Heng NC, Chilcott CN, Reid G, Tagg JR.
    Antonie Van Leeuwenhoek; 2006 Oct; 90(3):269-80. PubMed ID: 16871420
    [Abstract] [Full Text] [Related]

  • 4. New insights into the mode of action of the lantibiotic salivaricin B.
    Barbour A, Tagg J, Abou-Zied OK, Philip K.
    Sci Rep; 2016 Aug 16; 6():31749. PubMed ID: 27526944
    [Abstract] [Full Text] [Related]

  • 5. Prevention of streptococcal pharyngitis by anti-Streptococcus pyogenes bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius.
    Tagg JR.
    Indian J Med Res; 2004 May 16; 119 Suppl():13-6. PubMed ID: 15232154
    [Abstract] [Full Text] [Related]

  • 6. Salivaricin A2 and the novel lantibiotic salivaricin B are encoded at adjacent loci on a 190-kilobase transmissible megaplasmid in the oral probiotic strain Streptococcus salivarius K12.
    Hyink O, Wescombe PA, Upton M, Ragland N, Burton JP, Tagg JR.
    Appl Environ Microbiol; 2007 Feb 16; 73(4):1107-13. PubMed ID: 17194838
    [Abstract] [Full Text] [Related]

  • 7. Production of the lantibiotic salivaricin A and its variants by oral streptococci and use of a specific induction assay to detect their presence in human saliva.
    Wescombe PA, Upton M, Dierksen KP, Ragland NL, Sivabalan S, Wirawan RE, Inglis MA, Moore CJ, Walker GV, Chilcott CN, Jenkinson HF, Tagg JR.
    Appl Environ Microbiol; 2006 Feb 16; 72(2):1459-66. PubMed ID: 16461700
    [Abstract] [Full Text] [Related]

  • 8. Variable characteristics of bacteriocin-producing Streptococcus salivarius strains isolated from Malaysian subjects.
    Barbour A, Philip K.
    PLoS One; 2014 Feb 16; 9(6):e100541. PubMed ID: 24941127
    [Abstract] [Full Text] [Related]

  • 9. Intra- and interspecies signaling between Streptococcus salivarius and Streptococcus pyogenes mediated by SalA and SalA1 lantibiotic peptides.
    Upton M, Tagg JR, Wescombe P, Jenkinson HF.
    J Bacteriol; 2001 Jul 16; 183(13):3931-8. PubMed ID: 11395456
    [Abstract] [Full Text] [Related]

  • 10. Enhanced production, purification, characterization and mechanism of action of salivaricin 9 lantibiotic produced by Streptococcus salivarius NU10.
    Barbour A, Philip K, Muniandy S.
    PLoS One; 2013 Jul 16; 8(10):e77751. PubMed ID: 24147072
    [Abstract] [Full Text] [Related]

  • 11. Salivaricin G32, a Homolog of the Prototype Streptococcus pyogenes Nisin-Like Lantibiotic SA-FF22, Produced by the Commensal Species Streptococcus salivarius.
    Wescombe PA, Dyet KH, Dierksen KP, Power DA, Jack RW, Burton JP, Inglis MA, Wescombe AL, Tagg JR.
    Int J Microbiol; 2012 Jul 16; 2012():738503. PubMed ID: 22567013
    [Abstract] [Full Text] [Related]

  • 12. Genome sequence of the lantibiotic bacteriocin producer Streptococcus salivarius strain K12.
    Barretto C, Alvarez-Martin P, Foata F, Renault P, Berger B.
    J Bacteriol; 2012 Nov 16; 194(21):5959-60. PubMed ID: 23045482
    [Abstract] [Full Text] [Related]

  • 13. Covalent Structure and Bioactivity of the Type AII Lantibiotic Salivaricin A2.
    Geng M, Austin F, Shin R, Smith L.
    Appl Environ Microbiol; 2018 Mar 01; 84(5):. PubMed ID: 29269497
    [Abstract] [Full Text] [Related]

  • 14. Characterization of salivaricin CRL 1328, a two-peptide bacteriocin produced by Lactobacillus salivarius CRL 1328 isolated from the human vagina.
    Vera Pingitore E, Hébert EM, Nader-Macías ME, Sesma F.
    Res Microbiol; 2009 Mar 01; 160(6):401-8. PubMed ID: 19591924
    [Abstract] [Full Text] [Related]

  • 15. Synthesis of trypsin-resistant variants of the Listeria-active bacteriocin salivaricin P.
    O'Shea EF, O'Connor PM, Cotter PD, Ross RP, Hill C.
    Appl Environ Microbiol; 2010 Aug 01; 76(16):5356-62. PubMed ID: 20581174
    [Abstract] [Full Text] [Related]

  • 16. Isolation and characterization of the lantibiotic salivaricin A and its structural gene salA from Streptococcus salivarius 20P3.
    Ross KF, Ronson CW, Tagg JR.
    Appl Environ Microbiol; 1993 Jul 01; 59(7):2014-21. PubMed ID: 8357242
    [Abstract] [Full Text] [Related]

  • 17. Evolution of Lantibiotic Salivaricins: New Weapons to Fight Infectious Diseases.
    Barbour A, Wescombe P, Smith L.
    Trends Microbiol; 2020 Jul 01; 28(7):578-593. PubMed ID: 32544444
    [Abstract] [Full Text] [Related]

  • 18. Modifying the Lantibiotic Mutacin 1140 for Increased Yield, Activity, and Stability.
    Geng M, Smith L.
    Appl Environ Microbiol; 2018 Aug 01; 84(15):. PubMed ID: 29776930
    [Abstract] [Full Text] [Related]

  • 19. Ubericin A, a class IIa bacteriocin produced by Streptococcus uberis.
    Heng NC, Burtenshaw GA, Jack RW, Tagg JR.
    Appl Environ Microbiol; 2007 Dec 01; 73(23):7763-6. PubMed ID: 17933926
    [Abstract] [Full Text] [Related]

  • 20. Bioengineering of the model lantibiotic nisin.
    Field D, Cotter PD, Ross RP, Hill C.
    Bioengineered; 2015 Dec 01; 6(4):187-92. PubMed ID: 25970137
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.